Kodamaea ohmeri isolate from two immunocompromised patients: First report in Italy

Mycoses

Volumn 56, Issue 2, 2013, Pages 179-181

  Santino, I ^a   Bono, S ^b   Borruso, L ^a   Bove, M ^a   Cialdi, E ^a   Martinelli, D ^a   Alari, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b GENOMA Molecular Genetics Laboratory   (Italy)

Author keywords

Italy; Kodamaea ohmeri; Mucositis; Patients; Pneumonia

Indexed keywords

AMPHOTERICIN B; DNA 26S; FUNGAL DNA; ITRACONAZOLE; VORICONAZOLE;

AGAR MEDIUM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CASE REPORT; DNA SEQUENCE; FUNGUS ISOLATION; HUMAN; IMMUNOCOMPROMISED PATIENT; ITALY; KODAMAEA OHMERI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; YEAST;

ANTIFUNGAL AGENTS; ASCOMYCOTA; HUMANS; IMMUNOCOMPROMISED HOST; ITALY; MYCOSES; PNEUMONIA;

CANDIDA; FUNGI; KODAMAEA OHMERI;

EID: 84874330276     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2012.02232.x     Document Type: Article

References (14)

1. Yamada Y, Suzuki T, Matsuda M, Mikata K. The phylogeny of Yamadazyma ohmeri (Etchells et Bell) Billon Grand based on the partial sequences of 18S and 26S ribosomal RNAs: the proposal of Kodamaea gen. nov. (Saccharomycetaceae). Biosci Biotechnol Biochem 1995; 59: 1172-4.
2. MycoBank. Fungal Databases Nomenclature and Species Banks Online Taxonomic Novelties Submission. Utrecht, Netherland: CBS Fungal Biodiversity Centre, 2004: 9.
3. Bergman MM, Gagnon D, Doern GV. Pichia ohmeri fungemia. Diagn Microbiol Infect Dis 1998; 30: 229-31.
4. Han XY, Tarrand JJ, Escudero E. Infections by the yeast Kodomaea (Pichia) ohmeri: two cases and literature review. Eur J Clin Microbiol Infect Dis 2004; 23: 127-30.
5. Otag F, Kuyucu N, Erturan Z, Sen S, Emekdas G, Sugita T. An outbreak of Pichia ohmeri infection in the paediatric intensive care unit: case reports and review of the literature. Mycoses 2005; 48: 265-9.
6. Yang BH, Peng MY, Hou SJ, Sun JR, Lee SY, Lu JJ. Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature. Int J Infect Dis 2009; 3: 493-7.
7. De Barros J, Do Nascimento S, De Arau′jo F, Braz R, Andrade V. Kodamaea (Pichia) ohmeri fungemia in a pediatric patient admitted in a public hospital. Med Mycol 2009; 47: 775-9.
8. Choy BY, Wong SS, Chan TM, Lai KN. Pichia ohmeri peritonitis in a patient on CAPD: response to treatment with amphotericin. Perit Dial Int 2000; 20: 91.
9. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am 2008; 52: 61-77.
10. Shin DH, Park JH, Shin JH, Suh SP, Ryang DW, Kim SJ. Pichia ohmeri fungemia associated with phlebitis: successful treatment with amphotericin. B J Infect Chemother 2003; 9: 88-9.
11. Lee JS, Shin JH, Kim MN et al. Kodamaea ohmeri isolates from patients in a university hospital: identification, antifungal susceptibility, and pulsefield gel electrophoresis analysis. J Clin Microbiol 2007; 45: 1005-10.
12. Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH. The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med 2001; 111: 528-34.
13. Shaaban H, Choo HF, Boghossian J, Perez G. Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature. Mycopathologia 2010; 170: 223-8.
14. Chiu CH, Wang YC, Shang ST, Chang FY. Kodamaea ohmeri fungaemia successfully treated with caspofungin. Int J Antimicrob Agents 2010; 35: 93-9.